Company Performance Metrics
Kevin Sullivan: Chief Executive Officer - FounderPast Role: Appili Therapeutics, Founder & CEO- John Frampton: Chief Science Officer
3DBioFibR is a biotechnology company that develops and manufactures biopolymer fibers for tissue engineering and advanced biomaterial applications. The company uses a patented dry-spinning technology to produce collagen fibers that replicate the structural, biochemical, and biomechanical properties of natural collagen. Its product portfolio
includes collagen-based materials for 3D bioprinting, hydrogels, cell culture, and tissue engineering research, as well as custom collagen scaffolds for specialized applications. In addition to collagen, the company applies its manufacturing platform to other biopolymers, including spider silk, fibrin, and chitosan, for use in biomedical and advanced material research. The company collaborates with research institutions and industry partners to support the development of biomaterials for regenerative medicine, life sciences, and other engineering applications.